• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

感染HIV且心血管风险为低/中度至高度人群中他汀类药物处方的性别差异

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.

作者信息

Abela Irene A, Chammartin Frédérique, Amstutz Alain, Surial Bernard, Ballif Marie, Marzolini Catia, Aebi-Popp Karoline, Notter Julia, Segeral Olivier, Stoeckle Marcel, Cavassini Matthias, Bernasconi Enos, Günthard Huldrych F, Kouyos Roger D, Pasin Chloé

机构信息

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

出版信息

Open Forum Infect Dis. 2024 Sep 9;11(9):ofae502. doi: 10.1093/ofid/ofae502. eCollection 2024 Sep.

DOI:10.1093/ofid/ofae502
PMID:39296341
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11409876/
Abstract

The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

摘要

“缓解”试验表明，对于心血管疾病（CVD）低风险的HIV感染者，可考虑进行原发性心血管疾病预防。我们发现，心血管疾病低/中度风险和高风险的顺性别女性比顺性别男性接受他汀类药物治疗的可能性更小。需要努力确保在基于他汀类药物的心血管疾病预防方面获得平等的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c45/11409876/de6dcce384c2/ofae502f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c45/11409876/de6dcce384c2/ofae502f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c45/11409876/de6dcce384c2/ofae502f1.jpg

相似文献

1
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.感染HIV且心血管风险为低/中度至高度人群中他汀类药物处方的性别差异
Open Forum Infect Dis. 2024 Sep 9;11(9):ofae502. doi: 10.1093/ofid/ofae502. eCollection 2024 Sep.
2
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.在人类免疫缺陷病毒感染者和未感染者的真实队列中，根据种族、民族和 HIV 状况，他汀类药物的使用和降脂效果存在差异。
Am Heart J. 2019 Mar;209:79-87. doi: 10.1016/j.ahj.2018.11.012. Epub 2018 Dec 20.
3
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease.心血管疾病患者基于证据的他汀类药物治疗中的性别差异。
Am J Cardiol. 2015 Jan 1;115(1):21-6. doi: 10.1016/j.amjcard.2014.09.041. Epub 2014 Oct 12.
4
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.依折麦布用于预防心血管疾病和全因死亡事件。
Cochrane Database Syst Rev. 2018 Nov 19;11(11):CD012502. doi: 10.1002/14651858.CD012502.pub2.
5
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).随机预防 HIV 血管事件试验（REPRIEVE）的原理和设计。
Am Heart J. 2019 Jun;212:23-35. doi: 10.1016/j.ahj.2018.12.016. Epub 2019 Mar 4.
6
Sex differences in the intensity of statin prescriptions at initiation in a primary care setting.在初级保健环境中开始使用他汀类药物时的性别差异。
Heart. 2024 Jul 10;110(15):981-987. doi: 10.1136/heartjnl-2023-323722.
7
Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.基层医疗中他汀类药物用于二级预防的使用率较低：瑞典北部人群的一项调查
BMC Fam Pract. 2016 Aug 11;17(1):110. doi: 10.1186/s12875-016-0505-0.
8
Statins for primary cardiovascular disease prevention among people with HIV: emergent directions.他汀类药物用于预防 HIV 感染者的主要心血管疾病：新兴方向。
Curr Opin HIV AIDS. 2022 Sep 1;17(5):293-300. doi: 10.1097/COH.0000000000000752. Epub 2022 Jul 16.
9
Treatment and Response to Statins: Gender-related Differences.他汀类药物的治疗和反应：与性别相关的差异。
Curr Med Chem. 2017;24(24):2628-2638. doi: 10.2174/0929867324666161118094711.
10
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.HIV 感染者和已知动脉粥样硬化性心血管疾病患者中他汀类药物处方的差异。
Am Heart J. 2022 Jul;249:12-22. doi: 10.1016/j.ahj.2022.03.006. Epub 2022 Mar 19.

引用本文的文献

1
Lipid Profile Management in Secondary Prevention in Spain: Data from the BDCAP Registry in Spain (LIPIDSPAIN).西班牙二级预防中的血脂管理：来自西班牙BDCAP注册研究（LIPIDSPAIN）的数据
J Clin Med. 2025 Aug 26;14(17):6037. doi: 10.3390/jcm14176037.

本文引用的文献

1
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.2023 年欧洲艾滋病临床学会指南 12.0 重大修订版。
HIV Med. 2023 Nov;24(11):1126-1136. doi: 10.1111/hiv.13542. Epub 2023 Oct 18.
2
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.匹伐他汀预防 HIV 感染患者的心血管疾病。
N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23.
3
Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk.
评估高心血管风险患者中他汀类药物治疗不接受率和低密度脂蛋白胆固醇水平的性别差异。
JAMA Netw Open. 2023 Feb 1;6(2):e231047. doi: 10.1001/jamanetworkopen.2023.1047.
4
Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes.作为心血管疾病结局机制决定因素的性别与性别的偏差
Can J Cardiol. 2022 Dec;38(12):1865-1880. doi: 10.1016/j.cjca.2022.09.009. Epub 2022 Sep 15.
5
Disparities in the Prescription of Statins in the Primary Care Setting: A Retrospective Observational Study.初级保健环境中他汀类药物处方的差异：一项回顾性观察研究。
Curr Probl Cardiol. 2022 Nov;47(11):101329. doi: 10.1016/j.cpcardiol.2022.101329. Epub 2022 Jul 20.
6
Gaps and Disparities in Primary Prevention Statin Prescription During Outpatient Care.初级预防他汀类药物处方在门诊护理中的差距和差异。
Am J Cardiol. 2021 Dec 15;161:36-41. doi: 10.1016/j.amjcard.2021.08.070.
7
Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013-2019.2013-2019 年瑞士降血脂药物的使用模式和成本。
Swiss Med Wkly. 2021 Sep 1;151:w30018. doi: 10.4414/SMW.2021.w30018. eCollection 2021 Aug 30.
8
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).队列简介更新：瑞士艾滋病毒队列研究（SHCS）。
Int J Epidemiol. 2022 Feb 18;51(1):33-34j. doi: 10.1093/ije/dyab141.
9
Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.2006-2019 年英国初级保健中 2 型糖尿病患者基于指南建议使用他汀类药物起始治疗的种族差异：一项队列研究。
PLoS Med. 2021 Jun 29;18(6):e1003672. doi: 10.1371/journal.pmed.1003672. eCollection 2021 Jun.
10
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.SCORE2-OP 风险预测算法：估计四个地理风险地区老年人的新发心血管事件风险。
Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.